Taken together, with a small-scale cohort of genetic screening in 50 oocyte MI-arrested patients, our study adds novel pathogenic variants of MAD2L1BP to the genetic mutational spectrum underlying human oocyte maturation arrest, and likely provides novel diagnostic and therapeutic avenues for primary female infertility in the future. This evidence concerns the gene MAD2L1BP and female infertility.